Got in when they announced the mj subsidiary. But this news of the acquisition just makes it better and better.I have been adding little by little and will be holding till we hit a buck.
I love the way this stock is trading. It gaps and settles down and lets investors accumulate. This company is going places. The management is top notch and the right moves are being made. Their cell Iin box technology will be sought after by big pharma. No doubt.
Phase 2 showed us some rather interesting results compared with Gemzar. Can anyone honestly tell me why phase 3 results would be any different? With fast track involved too. Buy now. Hold for 6mos to a year and you could have a 4 bagger or more.
That cell encapsulation process this company has for pancreatic cancer and diabetes is going to change treatment of diseases. Adding mj to mix makes it even better. Holding onto my shares.
Ran into article that states nvlx has potential to rival lilly's gemzar...forbes just did article on nvlx...a penny stock trading at .075...they have done a phase 2b that validated their tech is legit...what.do you guys think...
PR yesterday announced agreement between Fisher and NVLX involving upcoming pancreatic cancer phase 3.To read this pr visit nvlx. NVLX up yesterday but this company is still under radar.
I think this is a rare opportunity to get in when a company is just about to take off. Great future here.
Check recent forbes article about nvlx (nuvilex). Great action and today info about a 200m short position came out. Seems there is talk of a phase 3 coming soon and still relatively low priced. Might be worth a look.